NFKBIZ and cancer: Further, an upregulation of CXCR4, the receptor of the cytokine CXCL12 (known to exclude T-cells in cancer) was linked to increased CXCL12 and a downregulation of NF-kappa-B inhibitor zeta (NFKBIZ) in fibroblast foci.